在患有痴呆症的患者中,塞马格卢提德的神经精神病学副作用
Namirah Jamshed1, Syed Tabish Rehman2, Noor Khan3
1Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, USA namirah.jamshed@utsouthwestern.edu.
BMJ case reports
|August 4, 2025
概括
塞马格卢提德可能会导致严重的心理和身体副作用,如冷漠和体重减轻,特别是在痴呆症的老年人中. 停止服用药物导致症状改善,强调需要仔细监测.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 塞马格卢提德是一种类似于葡萄糖的-1受体激动剂,用于2型糖尿病.
- 老年人,特别是那些有认知障碍的人,可能更容易受到药物副作用的影响.
- 对于老年人群中塞马格卢提德的安全性数据有限.
研究的目的:
- 报告一名患有痴呆症和2型糖尿病的老年妇女与塞马格卢提德相关的严重不良反应.
- 为了突出塞马格卢提德的潜在精神和身体副作用.
- 强调需要仔细监测和考虑在脆弱患者群体中停止治疗的必要性.
主要方法:
- 一个老年女性患者的病例报告,患有2型糖尿病和痴呆症.
- 开始接受西马格卢提德治疗.
- 观察患者对塞马格卢提德的反应,包括不良事件和停止治疗后的结果.
主要成果:
- 患者在开始服用西马格卢提德后出现了显著的冷漠,体重减轻,食欲下降.
- 这些不良症状在停止服用药物后明显改善.
- 这一案例表明,塞马格卢提德与严重的精神/身体不良事件之间存在潜在的联系.
结论:
- 医疗保健提供者应警西马格卢提德的潜在精神病副作用,特别是在认知障碍的老年人中.
- 如果出现不良症状,密切监测和立即考虑停止药物治疗至关重要.
- 需要进一步的研究,以了解塞马格卢提德在老年人群中的安全性.
相关概念视频
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Antipsychotic Drugs: Therapeutic Uses and Side Effects
382
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
382
Antidepressant Drugs: MAOIs and Other Agents
353
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
353
Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380


